Omega-3 marine triglycerides and Polyp - a phase IV clinical study of FDA data

Summary:

Polyp is reported as a side effect among people who take Omega-3 marine triglycerides (fish oil), especially for people who are female, 60+ old, also take Fosamax, and have Osteoporosis.

The phase IV clinical study analyzes which people have Polyp when taking Omega-3 marine triglycerides. It is created by eHealthMe based on reports of 1,823 people who have side effects when taking Omega-3 marine triglycerides from the FDA, and is updated regularly.

What is Omega-3 marine triglycerides?

Omega-3 marine triglycerides has active ingredients of fish oil. eHealthMe is studying from 1,837 Omega-3 marine triglycerides users. Check the latest studies of Omega-3 marine triglycerides.

What is Polyp?

Polyp is found to be associated with 798 drugs and 777 conditions by eHealthMe. Check the latest studies of Polyp.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

1,823 people reported to have side effects when taking Omega-3 marine triglycerides.
Among them, 11 people (0.6%) have Polyp.

Could Omega-3 marine triglycerides cause Polyp?

Among these 11 people:

What is the gender of people who have Polyp when taking Omega-3 marine triglycerides? *

female: 70 %
male: 30 %

What is the age of people who have Polyp when taking Omega-3 marine triglycerides? *

What are other drugs people take besides Omega-3 marine triglycerides? *

What are other side effects people have besides Polyp? *

Femur Fracture: 9 people, 81.82%
Fall: 8 people, 72.73%
Intervertebral Disc Degeneration (spinal disc degeneration): 8 people, 72.73%
Back Pain: 7 people, 63.64%
Bone Disorder: 6 people, 54.55%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 54.55%
Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 6 people, 54.55%
Joint Pain: 6 people, 54.55%
Hypermetropia (abnormal condition in which vision for distant objects is better than for near objects): 5 people, 45.45%
Haemorrhagic Anaemia (anaemia due to excessive bleeding): 5 people, 45.45%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 63.64%
Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 18.18%
Diabetes: 2 people, 18.18%
Weight Loss: 1 person, 9.09%
Type 2 Diabetes: 1 person, 9.09%
Stress And Anxiety: 1 person, 9.09%
Percutaneous Coronary Intervention: 1 person, 9.09%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Omega-3 marine triglycerides and have Polyp?

- Check whether Polyp is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omega-3 marine triglycerides:

Omega-3 marine triglycerides (1,837 reports)

Polyp treatments and more:

Polyp (9,393 reports)

Browse all side effects of Omega-3 marine triglycerides:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Polyp:

Polyp (798 drugs)

Browse all the conditions that are associated with Polyp:

Polyp (777 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fish oil (the active ingredients of Omega-3 marine triglycerides) and Omega-3 marine triglycerides (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.